Clinical Trial Update: Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating low-dose tipranavir/ritonavir pharmacokinetics in treatment-naive HIV patients; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Ritonavir (Ritonavir)
• Tipranavir (tipranavir)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2009-07-08